We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$42.4B
1-Year Est. Return
181.11%
This Fund
S&P 500
This Quarter
Est. Return
+71.98%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$42.4B
AUM Growth
+$14.2B
(+50%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
3.09%
Top 10 Holdings %
Top 10 Hldgs %
39.95%
Holding
284
New
32
Increased
89
Reduced
83
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$416M |
| 2 |
Palo Alto Networks
PANW
|
+$383M |
| 3 |
CrowdStrike
CRWD
|
+$306M |
| 4 |
AstraZeneca
AZN
|
+$235M |
| 5 |
Silicon Motion
SIMO
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$548M |
| 2 |
Ciena
CIEN
|
+$310M |
| 3 |
Broadcom
AVGO
|
+$297M |
| 4 |
Lumentum
LITE
|
+$294M |
| 5 |
Advanced Micro Devices
AMD
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 50.75% |
| 2 | Miscellaneous | 16.86% |
| 3 | Healthcare | 13.2% |
| 4 | Financials | 8.03% |
| 5 | Communication Services | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Johnson & Johnson
JNJ
$642B
| $199M | 0.47% |
+783,595
| New | +$183M |
|
52
Cytokinetics
CYTK
$10.1B
| $192M | 0.45% |
2,253,649
+592,401
| +36% | +$42.5M |
|
53
Akamai
AKAM
$15.2B
| $186M | 0.44% |
1,575,971
+279,306
| +22% | +$34.8M |
|
54
Rhythm Pharmaceuticals
RYTM
$7.21B
| $185M | 0.44% |
1,663,632
+48,046
| +3% | +$4.34M |
|
55
Caterpillar
CAT
$360B
| $178M | 0.42% |
167,175
+21,819
| +15% | +$19.2M |
|
56
Teva Pharmaceuticals
TEVA
$45.1B
| $177M | 0.42% |
5,212,749
+37,691
| +0.7% | +$1.26M |
|
57
Arcutis Biotherapeutics
ARQT
$3B
| $173M | 0.41% |
6,606,945
+940,005
| +17% | +$21.9M |
|
58
Amphenol
APH
$194B
| $172M | 0.41% |
1,954,662
+702,722
| +56% | +$50.7M |
|
59
ServiceNow
NOW
$147B
| $168M | 0.4% |
+1,694,573
| New | +$168M |
|
60
Ascendis Pharma A/S
ASND
$17.4B
| $165M | 0.39% |
616,908
-34,804
| -5% | -$8.13M |
|
61
Onto Innovation
ONTO
$13.8B
| $154M | 0.36% |
+406,645
| New | +$115M |
|
62
BridgeBio Pharma
BBIO
$14.1B
| $154M | 0.36% |
2,063,609
-455,697
| -18% | -$31.9M |
|
63
Essent Group
ESNT
$6.13B
| $153M | 0.36% |
2,379,000
-171,000
| -7% | -$10.4M |
|
64
Markel Group
MKL
$22.1B
| $153M | 0.36% |
78,250
-1,750
| -2% | -$3.27M |
|
65
W.R. Berkley
WRB
$25.9B
| $150M | 0.35% |
2,130,000
-145,000
| -6% | -$9.72M |
|
66
Alnylam Pharmaceuticals
ALNY
$33.5B
| $145M | 0.34% |
482,751
+225,077
| +87% | +$67.9M |
|
67
Travelers Companies
TRV
$78.3B
| $139M | 0.33% |
420,000
-57,500
| -12% | -$17.4M |
|
68
Amgen
AMGN
$206B
| $134M | 0.32% |
+369,086
| New | +$126M |
|
69
Madrigal Pharmaceuticals
MDGL
$12.3B
| $131M | 0.31% |
244,274
-45,036
| -16% | -$23.1M |
|
70
Revolution Medicines
RVMD
$44B
| $129M | 0.31% |
690,316
-443,614
| -39% | -$64.8M |
|
71
Cogent Biosciences
COGT
$5.8B
| $125M | 0.3% |
+3,232,905
| New | +$113M |
|
|
BNY
72
Bank of New York Mellon
BNY
$107B
| $120M | 0.28% |
827,041
+341,887
| +70% | +$46.7M |
|
73
Everest Group
EG
$14.3B
| $118M | 0.28% |
329,500
-74,000
| -18% | -$25.3M |
|
|
ORKA
74
Oruka Therapeutics
ORKA
$6.12B
| $117M | 0.28% |
1,228,609
+180,916
| +17% | +$12.1M |
|
75
MKS Inc
MKSI
$18.1B
| $116M | 0.27% |
260,442
+188,231
| +261% | +$58.9M |
|
Similar funds
GAM
SAM
Polar Capital Holdings's Q2 2026 Portfolio in Review
As of Q2 2026, Polar Capital Holdings held 284 positions worth $42.4B, up 50% from $28.2B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Polar Capital Holdings deployed $1.31B of net new capital in Q2 2026, opening 32 new positions and adding to 89 existing holdings. Its largest new stake was Palo Alto Networks: 1,672,688 shares worth $570M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 42% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Sandisk, an estimated $548M trimmed.
- Polar Capital Holdings's largest Q2 2026 buy was Palo Alto Networks: 1,672,688 shares worth $570M.
- Polar Capital Holdings added most to NVIDIA in Q2 2026, an estimated $416M increase.
- Polar Capital Holdings's biggest Q2 2026 reduction was Sandisk, cutting an estimated $548M.
- Polar Capital Holdings fully exited Ciena in Q2 2026, selling an estimated $310M.
- Polar Capital Holdings's ten largest holdings make up 40% of its $42.4B portfolio in Q2 2026.
- Polar Capital Holdings opened 32 new positions and closed 47 in Q2 2026.
- Polar Capital Holdings's portfolio value rose 50% quarter-over-quarter to $42.4B.
Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.